Intrepid Financial Planning Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Intrepid Financial Planning Group's PFE Position: Q2 2026 in Review
Intrepid Financial Planning Group reduced its Pfizer (PFE) stake by 1.1% in Q2 2026, selling an estimated $2.35K and leaving 8,476 shares worth $204K. The position accounts for 0.07% of the portfolio, ranked #127.
Intrepid Financial Planning Group first reported a position in PFE in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.11M in Q2 2022. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Intrepid Financial Planning Group held 8,476 shares of Pfizer worth $204K as of Q2 2026.
- Intrepid Financial Planning Group sold 90 Pfizer shares in Q2 2026, an estimated $2.35K.
- Pfizer made up 0.07% of Intrepid Financial Planning Group's portfolio in Q2 2026, its #127 holding.
- Intrepid Financial Planning Group first reported a position in Pfizer in Q2 2022 and has held it in 17 quarters since.
- Intrepid Financial Planning Group's Pfizer position peaked at $1.11M in Q2 2022.
- 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Intrepid Financial Planning Group's 13F filing for Q2 2026, filed 12 Aug 2026.